Burnett Patrick's Form 4 filing
Arcutis Biotherapeutics, Inc. (ARQT) · filed Aug 22, 2023
- Accession no.
- 0001787306-23-000083
- Filed
- Aug 22, 2023
- Trade date
- Aug 21, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $11.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Burnett PatrickCIK 0001741987 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2023 | Common Stock | SSaleDisposed | −300 | $7.05 | −$2,115 | 59,662 | Direct | |
| Aug 21, 2023 | Common Stock | SSaleDisposed | −1,305 | $7.04 | −$9,187.2 | 58,357 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Reporting Person's Title: Senior Vice President and Chief Medical Officer